123 related articles for article (PubMed ID: 21107110)
1. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
Yeo SG; Kim DY; Kim TH; Chang HJ; Oh JH; Park W; Choi DH; Nam H; Kim JS; Cho MJ; Kim JH; Park JH; Kang MK; Koom WS; Kim JS; Nam TK; Chie EK; Kim JS; Lee KJ
Ann Surg; 2010 Dec; 252(6):998-1004. PubMed ID: 21107110
[TBL] [Abstract][Full Text] [Related]
2. Primary Surgery Followed by Selective Chemoradiotherapy Versus Preoperative Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer: A Randomized Clinical Trial.
Li J; Hu YT; Liu CC; Wang LH; Ju HX; Huang XF; Chi P; Du JL; Wang JP; Xiao Y; Lin GL; Zhang W; Zhao H; Liu M; Song YM; Xu D; Wang JW; Sun LF; Xie HT; Cao HF; Xiao Q; Wang J; Wu QB; Li DC; Dai S; Jiang WZ; Shen L; Yuan Y; Wang ZQ; Ding KF
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):884-895. PubMed ID: 38185388
[TBL] [Abstract][Full Text] [Related]
3. Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with locally advanced rectal cancer.
Conde S; Borrego M; Teixeira T; Teixeira R; Corbal M; Sá A; Soares P
Rep Pract Oncol Radiother; 2010; 15(3):51-9. PubMed ID: 24376924
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Nodal Disease in Rectal Cancer Patients with Complete Mucosal Response to Neoadjuvant Therapy.
Emile SH; Maron DJ; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
World J Surg; 2023 Aug; 47(8):2013-2022. PubMed ID: 37084107
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
Peng J; Ma W; Zhou Z; Gu Y; Lu Z; Zhang R; Pan Z
J Cancer; 2018; 9(6):1067-1077. PubMed ID: 29581786
[No Abstract] [Full Text] [Related]
6. Nutritional status indicators predict tolerability to adjuvant chemotherapy in patients with stage II/III rectal cancer undergoing neoadjuvant chemoradiotherapy.
Abe S; Nozawa H; Sasaki K; Murono K; Emoto S; Yokoyama Y; Matsuzaki H; Nagai Y; Shinagawa T; Sonoda H; Ishihara S
Digestion; 2024 May; ():. PubMed ID: 38810604
[TBL] [Abstract][Full Text] [Related]
7. Analysis of risk characteristics for early progression and late progression in locally advanced rectal cancer patients: a large population-based and validated study.
Yu Y; Wu H; Qiu J; Wu S; Gan Y; Shao L; Lin C; Hong L; Wu J
Support Care Cancer; 2024 May; 32(6):340. PubMed ID: 38733415
[TBL] [Abstract][Full Text] [Related]
8. Treatment Outcomes of Olfactory Neuroblastoma: A Multicenter Study by the Korean Sinonasal Tumor and Skull Base Surgery Study Group.
Hong SD; Park SI; Kim JH; Heo SJ; Cho SW; Won TB; Cho HJ; Lee DH; Mun SJ; Park SK; Kim YW; Kim DY
Clin Exp Otorhinolaryngol; 2024 May; 17(2):137-146. PubMed ID: 38404243
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.
Breugom AJ; Swets M; Bosset JF; Collette L; Sainato A; Cionini L; Glynne-Jones R; Counsell N; Bastiaannet E; van den Broek CB; Liefers GJ; Putter H; van de Velde CJ
Lancet Oncol; 2015 Feb; 16(2):200-7. PubMed ID: 25589192
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
12. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
Sauer R; Liersch T; Merkel S; Fietkau R; Hohenberger W; Hess C; Becker H; Raab HR; Villanueva MT; Witzigmann H; Wittekind C; Beissbarth T; Rödel C
J Clin Oncol; 2012 Jun; 30(16):1926-33. PubMed ID: 22529255
[TBL] [Abstract][Full Text] [Related]
13. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.
Maas M; Beets-Tan RG; Lambregts DM; Lammering G; Nelemans PJ; Engelen SM; van Dam RM; Jansen RL; Sosef M; Leijtens JW; Hulsewé KW; Buijsen J; Beets GL
J Clin Oncol; 2011 Dec; 29(35):4633-40. PubMed ID: 22067400
[TBL] [Abstract][Full Text] [Related]
14. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
Kasi A; Abbasi S; Handa S; Al-Rajabi R; Saeed A; Baranda J; Sun W
JAMA Netw Open; 2020 Dec; 3(12):e2030097. PubMed ID: 33326026
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.
Hong YS; Kim SY; Lee JS; Nam BH; Kim KP; Kim JE; Park YS; Park JO; Baek JY; Kim TY; Lee KW; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
J Clin Oncol; 2019 Nov; 37(33):3111-3123. PubMed ID: 31593484
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial.
Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Wu X; Peng J; Ren D; Wang J
J Clin Oncol; 2019 Dec; 37(34):3223-3233. PubMed ID: 31557064
[TBL] [Abstract][Full Text] [Related]
17. Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
Petrelli F; Trevisan F; Cabiddu M; Sgroi G; Bruschieri L; Rausa E; Ghidini M; Turati L
Ann Surg; 2020 Mar; 271(3):440-448. PubMed ID: 31318794
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
van der Valk MJM; Hilling DE; Bastiaannet E; Meershoek-Klein Kranenbarg E; Beets GL; Figueiredo NL; Habr-Gama A; Perez RO; Renehan AG; van de Velde CJH;
Lancet; 2018 Jun; 391(10139):2537-2545. PubMed ID: 29976470
[TBL] [Abstract][Full Text] [Related]
19. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
[TBL] [Abstract][Full Text] [Related]
20. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
